Merck's G650ER lands in southwest Michigan days after FDA-approved Keytruda combo for breast cancer

Merck's Gulfstream G650ER, tail number N822MK, was tracked departing Greenville-Spartanburg International Airport on June 25 and arriving at Southwest Michigan Regional Airport after a 1-hour, 22-minute flight. The aircraft reached a cruising altitude of 41,000 feet and a top ground speed of 467 knots.

If Merck personnel were aboard, the arrival would coincide with the fallout from two significant FDA approvals announced this week. On June 25, the FDA approved Merck's Keytruda in combination with Gilead's Trodelvy as a first-line treatment for advanced triple-negative breast cancer, per a Morningstar report. Additionally, on June 24, the FDA approved a Keytruda-Welireg combination for renal cell carcinoma, as covered by News USA Today. The timing suggests the flight could relate to internal strategy discussions or regional investor meetings following these oncology milestones.

The aircraft had flown from an area near Scranton, Pennsylvania, to a location near Greenville, South Carolina, two days prior, on June 23. Other recent flights from Merck's fleet show routine shuttling between the company's Morristown, New Jersey home base and locations in Florida, Tennessee, and New Jersey, consistent with the corporate travel pattern of a pharmaceutical giant managing a blockbuster oncology portfolio.